NCT06648486Completed
Robot-assisted Training
Evaluation of a Portable Isokinetic Knee Training Device for Quadriceps Rehabilitation in Children With SMA
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the long-term effects of isokinetic rehabilitation training in patients with spinal muscular atrophy (SMA). The main question it aims to answer is: • Does isokinetic training at fixed angular velocity improve muscle strength and functional recovery in SMA patients? Participants will: * Perform isokinetic training using a portable device with a fixed angular velocity. * Undergo long-term rehabilitation sessions, with assessments of muscle strength and overall functional improvement over the training period.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 13 (actual)
- First submitted
- 3 Oct 2024
- Start date
- 25 Feb 2025
- Primary completion date
- 30 Aug 2025
- Lead sponsor
- Peking University Third Hospital
- Diseases
- Spinal muscular atrophy
- NCT number
- NCT06648486
What you commit to
- Study type: Interventional
- Participants enrolled: 13
- From 25 Feb 2025 to the primary completion date, 30 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncontrolled hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg) or congestive heart failure classified as New York Heart Association (NYHA) Class III or IV;
Other
- Participants with severe comorbidities, implanted medical devices preventing MRI or claustrophobia were excluded from the study.
- Refusal to provide informed consent or inability to complete the entire study protocol, among other factors;
- Cognitively impaired or unable to comprehend the requirements of study participation.
Who the study is looking for
- Age range: 6-12 years old.
- Diagnosed with Type II Spinal Muscular Atrophy (SMA).
Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Third Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.